Cholesterol Drug Recalled

The U.S. Food and Drug Administration (FDA) announced a Class II recall of ezetimibe and simvastatin (Vytorin) tablets.

Each tablet has 20 mg of simvastatin and 10 mg of ezetimibe. The recall is due to the discovery of ezetimibe and simvastatin 10 mg/40 mg tablets in bottles of ezetimibe and simvastatin 10 mg/20 mg tablets.

The 1,000-count bottles were manufactured for a subsidiary of Merck & Co.

The impacted lot is #L013425, expiration November 2016. It was distributed in Kentucky, Mississippi, and Ohio.

You can read the report here.

--Stephanie Vaccaro

Reference:

1. U.S. Food and Drug Administration. Enforcement Report – Week of October 14, 2015. www.fda.gov. Accessed October 20, 2015.